What is the Alivus Life Sciences Ltd FII shareholding?

Foreign Institutional Investors (FIIs) hold 5.93% of the total equity shares of Alivus Life Sciences Ltd.

What is the Alivus Life Sciences Ltd DII shareholding?

Domestic Institutional Investors (DIIs) hold 7.03% of the total equity shares of Alivus Life Sciences Ltd.

How has the Alivus Life Sciences Ltd promoter holding changed?

The promoter holding in Alivus Life Sciences Ltd changed from 74.87% to 74.85% during the latest reported period.

How has the Alivus Life Sciences Ltd FII holding changed?

The FII holding in Alivus Life Sciences Ltd changed from 5.54% to 5.93% during the latest reported period.

How has the Alivus Life Sciences Ltd DII holding changed?

The DII holding in Alivus Life Sciences Ltd changed from 7.18% to 7.03% during the latest reported period.

Who are the major shareholders of Alivus Life Sciences Ltd?

The major shareholders of Alivus Life Sciences Ltd may include promoters, institutional investors and other significant shareholders holding substantial equity stakes.

Alivus Life Sciences Ltd Shareholding Pattern: Promoters, FII, DII & Public

Q: What is the Alivus Life Sciences Ltd public shareholding?

Public shareholders hold 12.19% of the total equity shares of Alivus Life Sciences Ltd as per the latest available data.

Alivus Life Sciences Ltd Share Price

Detail Overview

Pharmaceuticals - Indian - Bulk Drugs & Formln M/SNSE

₹1,269.00

+11.10(+0.88%)

As on 22 Oct 2026 at 15:56

As of 22 Oct 2026 at 15:56, Alivus Life Sciences Ltd is trading at ₹1,269.00. The 52-week range stands at ₹819.00–₹1,493.80, with a market cap of ₹15.56 thousand crore. At a P/E of 25.03 and a dividend yield of 0.39%, it is a mid-cap stock in the Pharmaceuticals sector.